{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:44:22Z","timestamp":1785451462217,"version":"3.56.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union under the 7th Framework Programme","award":["602\u2009478"],"award-info":[{"award-number":["602\u2009478"]}]},{"name":"Turku University Central Hospital","award":["11\u2009336"],"award-info":[{"award-number":["11\u2009336"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Hypothesis<\/jats:title>\n                    <jats:p>A sex difference in the clinical presentation of schizophrenia is well known. Males have on average an earlier symptom onset, worse functional capacity, and more negative symptoms. Studies on the neurobiological correlates of psychosis show that brain endocannabinoid system (ECS) is dysregulated in male patients with first-episode psychosis (FEP). We now evaluated whether the brain ECS is also altered in female patients with FEP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>In this cross-sectional case\u2013control study, brain CB1R availability was measured in 39 participants, including groups of male and female patients with FEP, and healthy control participants (HC) of similar age and sex (n\u2009=\u20098-11\/group). Brain CB1R availability was measured with the selective CB1R radiotracer [18F]FMPEP-d2 and positron emission tomography. Arterial input derived distribution volumes (VT) were extracted from regions of interest (ROI) representing the anterior cingulate cortex, hippocampus, thalamus, and putamen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Results<\/jats:title>\n                    <jats:p>Within-subjects analyses showed a regionally differential effect of ROI*sex*group (\u03b5\u2009=\u20090.77; F(2.31,80.85)\u2009=\u20094.31, P\u2009=\u2009.013). Simple effect analyses indicates that male FEP had significantly lower overall CB1R VT when compared to male HC (F(1,17)\u2009=\u200915.64, pFWER\u2009=\u20090.018), while female FEP VT did not differ from female HC (F(1,18)\u2009=\u20090.12, pFWER\u2009=\u20091). A regionally specific difference of VT between males and females with FEP (F(3,48)\u2009=\u20093.43, P\u2009=\u2009.024) did not survive the correction for multiple comparisons (pFWER\u2009=\u20090.14).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The availability of brain CB1R is differentially altered in males and females with early psychosis. Sex-related neurobiological patterns including the ECS may offer new treatment strategies for alleviating the core symptoms of psychotic disorders in male and female patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/schbul\/sbag038","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:22:19Z","timestamp":1772454139000},"source":"Crossref","is-referenced-by-count":1,"title":["The Brain Endocannabinoid System is Differentially Regulated in Male and Female Patients with First-Episode Psychosis"],"prefix":"10.1093","volume":"52","author":[{"given":"Heikki","family":"Laurikainen","sequence":"first","affiliation":[{"name":"Turku PET Centre, University of Turku and Turku University Hospital , 20521, Turku ,","place":["Finland"]},{"name":"Department of Psychiatry, University of Turku and Turku University Hospital , 20520, Turku ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetta-Liina","family":"Armio","sequence":"additional","affiliation":[{"name":"Turku PET Centre, University of Turku and Turku University Hospital , 20521, Turku ,","place":["Finland"]},{"name":"Department of Psychiatry, University of Turku and Turku University Hospital , 20520, Turku ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Tuominen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Turku and Turku University Hospital , 20520, Turku ,","place":["Finland"]},{"name":"University of Ottawa Institute of Mental Health Research , K1Z 7K4, Ottawa, ON ,","place":["Canada"]},{"name":"Department of Psychiatry, Faculty of Medicine, University of Ottawa , K1Z 7K4, Ottawa, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Nyman","sequence":"additional","affiliation":[{"name":"Department of Radiology, Turku University Hospital & University of Turku , 20521, Turku ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kirjavainen","sequence":"additional","affiliation":[{"name":"Turku PET Centre, University of Turku and Turku University Hospital , 20521, Turku ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Rajander","sequence":"additional","affiliation":[{"name":"Accelerator Laboratory, Turku PET Centre, \u00c5bo Akademi University , 20521, Turku ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja","family":"Haaparanta-Solin","sequence":"additional","affiliation":[{"name":"Turku PET Centre, University of Turku and Turku University Hospital , 20521, Turku ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Solin","sequence":"additional","affiliation":[{"name":"Turku PET Centre, University of Turku and Turku University Hospital , 20521, Turku ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmo","family":"Hietala","sequence":"additional","affiliation":[{"name":"Turku PET Centre, University of Turku and Turku University Hospital , 20521, Turku ,","place":["Finland"]},{"name":"Department of Psychiatry, University of Turku and Turku University Hospital , 20520, Turku ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"2026050508262504400_ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2021.789179","article-title":"Gender differences in clinical and psychosocial features among persons with schizophrenia: a mini review","volume":"12","author":"Giordano","year":"2021","journal-title":"Front Psychiatry"},{"key":"2026050508262504400_ref2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.eurpsy.2019.04.007","article-title":"Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning\u2014results from the EU-GEI study","volume":"59","author":"Menghini-M\u00fcller","year":"2019","journal-title":"Eur Psychiatry"},{"key":"2026050508262504400_ref3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1017\/S003329171200089X","article-title":"Gender difference in age at onset of schizophrenia: a meta-analysis","volume":"43","author":"Eranti","year":"2012","journal-title":"Psychol Med"},{"key":"2026050508262504400_ref4","doi-asserted-by":"publisher","first-page":"114997","DOI":"10.1016\/j.psychres.2022.114997","article-title":"Gender differences in the response to antipsychotic medication in patients with schizophrenia: an individual patient data meta-analysis of placebo-controlled studies","volume":"320","author":"Storosum","year":"2023","journal-title":"Psychiatry Res"},{"key":"2026050508262504400_ref5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00737-023-01371-8","article-title":"Sex differences in schizophrenia-spectrum diagnoses: results from a 30-year health record registry","volume":"27","author":"Ferrara","year":"2023","journal-title":"Arch Womens Ment Health"},{"key":"2026050508262504400_ref6","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials","volume":"41","author":"Fusar-Poli","year":"2015","journal-title":"Schizophr Bull"},{"key":"2026050508262504400_ref7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/schbul\/sbac041","article-title":"Maintenance treatment with antipsychotic drugs in schizophrenia: a Cochrane systematic review and meta-analysis","volume":"48","author":"Ceraso","year":"2022","journal-title":"Schizophr Bull"},{"key":"2026050508262504400_ref8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr Bull"},{"key":"2026050508262504400_ref9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"2026050508262504400_ref10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/npp.2016.258","article-title":"Presynaptic dopamine capacity in patients with treatment-resistant schizophrenia taking clozapine: an [18F]DOPA PET study","volume":"42","author":"Kim","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"2026050508262504400_ref11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/schbul\/sbr163","article-title":"Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [99mTc]-TRODAT-1 and a meta-analysis","volume":"39","author":"Chen","year":"2011","journal-title":"Schizophr Bull"},{"key":"2026050508262504400_ref12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.neuroimage.2007.10.053","article-title":"Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET","volume":"39","author":"Van Laere","year":"2008","journal-title":"Neuroimage"},{"key":"2026050508262504400_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119674","article-title":"Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PET","volume":"264","author":"Radhakrishnan","year":"2022","journal-title":"NeuroImage"},{"key":"2026050508262504400_ref14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jamapsychiatry.2019.1427","article-title":"In vivo availability of cannabinoid 1 receptor levels in patients with first-episode psychosis","volume":"76","author":"Borgan","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"2026050508262504400_ref15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.biopsych.2015.08.021","article-title":"Reduced brain cannabinoid receptor availability in schizophrenia","volume":"79","author":"Ranganathan","year":"2016","journal-title":"Biol Psychiatry"},{"key":"2026050508262504400_ref16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/glia.24246","article-title":"Endocannabinoid signaling in astrocytes","volume":"71","author":"Eraso-Pichot","year":"2023","journal-title":"Glia"},{"key":"2026050508262504400_ref17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol Psychiatry"},{"key":"2026050508262504400_ref18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"2026050508262504400_ref19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.psyneuen.2010.02.008","article-title":"Estrogenic regulation of limbic cannabinoid receptor binding","volume":"35","author":"Riebe","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"2026050508262504400_ref20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1006\/bbrc.2000.2406","article-title":"Sex steroid influence on cannabinoid CB1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland","volume":"270","author":"Gonz\u00e1lez","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2026050508262504400_ref21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejphar.2018.07.039","article-title":"Endocannabinoid system, stress and HPA axis","volume":"834","author":"Micale","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"2026050508262504400_ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020972","article-title":"The complex interplay between endocannabinoid system and the estrogen system in central nervous system and periphery","volume":"22","author":"Santoro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026050508262504400_ref23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.neuroimage.2013.04.052","article-title":"Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia","volume":"79","author":"Ceccarini","year":"2013","journal-title":"NeuroImage"},{"key":"2026050508262504400_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110096","article-title":"Endocannabinoid system in psychotic and mood disorders, a review of human studies","volume":"106","author":"Garani","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2026050508262504400_ref25","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1210\/en.2011-1643","article-title":"Minireview: endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior","volume":"153","author":"Gorzalka","year":"2012","journal-title":"Endocrinology Mar"},{"key":"2026050508262504400_ref26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.neuroimage.2018.10.013","article-title":"Sex difference in brain CB1 receptor availability in man","volume":"184","author":"Laurikainen","year":"2019","journal-title":"Neuroimage"},{"key":"2026050508262504400_ref27","doi-asserted-by":"publisher","first-page":"23059","DOI":"10.1038\/s41598-023-50426-4","article-title":"Sex-dimorphism in human serum endocannabinoid and n-acyl ethanolamine concentrations across the lifespan","volume":"13","author":"Amir Hamzah","year":"2023","journal-title":"Sci Rep"},{"key":"2026050508262504400_ref28","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/mp.2013.61","article-title":"Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study","volume":"18","author":"Neumeister","year":"2013","journal-title":"Mol Psychiatry"},{"key":"2026050508262504400_ref29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/jcbfm.2015.46","article-title":"Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences","volume":"35","author":"Normandin","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"2026050508262504400_ref30","doi-asserted-by":"publisher","first-page":"110031","DOI":"10.1016\/j.pnpbp.2020.110031","article-title":"Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance","volume":"104","author":"Everett","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2026050508262504400_ref31","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1038\/s41591-024-03383-y","article-title":"Eleven clinical trials that will shape medicine in 2025","volume":"30","author":"Webster","year":"2024","journal-title":"Nat Med"},{"key":"2026050508262504400_ref32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/0269881111408956","article-title":"The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications","volume":"26","author":"Viveros","year":"2012","journal-title":"J Psychopharmacol"},{"key":"2026050508262504400_ref33","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1021\/jm800416m","article-title":"Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging","volume":"51","author":"Donohue","year":"2008","journal-title":"J Med Chem"},{"key":"2026050508262504400_ref34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"2026050508262504400_ref35","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"NeuroImage"},{"key":"2026050508262504400_ref36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.biopsych.2015.06.015","article-title":"The role of endocannabinoid Signaling in cortical inhibitory neuron dysfunction in schizophrenia","volume":"79","author":"Volk","year":"2016","journal-title":"Biol Psychiatry"},{"key":"2026050508262504400_ref37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0006-3223(91)90307-8","article-title":"Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients","volume":"30","author":"Sharma","year":"1991","journal-title":"Biol Psychiatry"},{"key":"2026050508262504400_ref38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0920-9964(94)00088-P","article-title":"Variability in BPRS definitions of positive and negative symptoms","volume":"17","author":"Nicholson","year":"1995","journal-title":"Schizophr Res"},{"key":"2026050508262504400_ref39","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr Bull"},{"key":"2026050508262504400_ref40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41582-023-00904-0","article-title":"Schizophrenia: from neurochemistry to circuits, symptoms and treatments","volume":"20","author":"Howes","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"2026050508262504400_ref41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2215-0366(18)30268-2","article-title":"The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study","volume":"5","author":"Jauhar","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2026050508262504400_ref42","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41467-020-15542-z","article-title":"Interplay between midbrain and dorsal anterior cingulate regions arbitrates lingering reward effects on memory encoding","volume":"11","author":"Aberg","year":"2020","journal-title":"Nat Commun"},{"key":"2026050508262504400_ref43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.neuron.2023.10.027","article-title":"CB1R dysfunction of inhibitory synapses in the ACC drives chronic social isolation stress-induced social impairments in male mice","volume":"112","author":"Guo","year":"2024","journal-title":"Neuron"},{"key":"2026050508262504400_ref44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuroimage.2018.10.049","article-title":"Childhood trauma moderates inhibitory control and anterior cingulate cortex activation during stress","volume":"185","author":"Zhai","year":"2019","journal-title":"Neuroimage"},{"key":"2026050508262504400_ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1131995","article-title":"Hormonal contraceptive exposure relates to changes in resting state functional connectivity of anterior cingulate cortex and amygdala","volume":"14","author":"Hidalgo-Lopez","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026050508262504400_ref46","doi-asserted-by":"publisher","first-page":"e60231","DOI":"10.1371\/journal.pone.0060231","article-title":"Population-based input function modeling for [(18)F]FMPEP-d2, an inverse agonist radioligand for cannabinoid CB1 receptors: validation in clinical studies","volume":"8","author":"Zanotti-Fregonara","year":"2013","journal-title":"PLoS One"},{"key":"2026050508262504400_ref47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2967\/jnumed.108.058628","article-title":"HRRT versus HR+ human brain PET studies: an interscanner test\u2013retest study","volume":"50","author":"van Velden","year":"2009","journal-title":"J Nucl Med"},{"key":"2026050508262504400_ref48","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1007\/s00259-025-07612-5","article-title":"Critical review of partial volume correction methods in PET and SPECT imaging: benefits, pitfalls, challenges, and future outlook","volume":"53","author":"Azimi","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026050508262504400_ref49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.schres.2022.06.022","article-title":"Selection bias in clinical studies of first-episode psychosis: a follow-up study","volume":"246","author":"Walta","year":"2022","journal-title":"Schizophr Res"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/3\/sbag038\/68212129\/sbag038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/3\/sbag038\/68212129\/sbag038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:26:35Z","timestamp":1777983995000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/doi\/10.1093\/schbul\/sbag038\/8667491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5,5]]},"published-print":{"date-parts":[[2026,4,10]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbag038","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,10]]},"article-number":"sbag038"}}